Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |